AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitos M 0.5mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Atos Lifesciences Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimitos M 0.5mg/500mg Tablet PR

Glimitos M 0.5mg/500mg tablets are classified as antidiabetic agents, a dual-medication formulation for adult type 2 diabetes management. This medication helps regulate blood glucose in diabetic patients. Administer Glimitos M with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar or feeling well. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle modifications are essential. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures, such as readily available glucose sources (sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimitos M 0.5mg/500mg Tablet PR

The provided text is "undefined". Therefore, no rewriting is possible.

Uses of Glimitos M 0.5mg/500mg Tablet PR

Managing Type 2 Diabetes

Major Benefits of Glimitos M 0.5mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Glimitos M 0.5mg/500mg Tablet PR with a meal.

Common Side effects of Glimitos M 0.5mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitos M 0.5mg/500mg Tablet PR:

Follow your doctor's instructions or refer to the product label for usage guidelines. Consume Glimitos M 0.5mg/500mg Tablet PR with a meal.

How Glimitos M 0.5mg/500mg Tablet PR works:

Glimitos M 0.5mg/500mg tablets are a dual-action antidiabetic formulation containing glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimitos M 0.5mg/500mg Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitos M 0.5mg/500mg Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Glimitos M 0.5mg/500mg Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimitos M 0.5mg/500mg Tablet PR, potentially requiring dosage modification. Physician consultation is recommended. Glimitos M 0.5mg/500mg Tablet PR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitos M 0.5mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically advised for individuals with mild to moderate hepatic dysfunction; however, it's contraindicated in those with severe liver disease.

What if you forget to take Glimitos M 0.5mg/500mg Tablet PR :

Should you forget a Glimitos M 0.5mg/500mg Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitos M 0.5mg/500mg Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimitos M 0.5mg/500mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Glimitos M 0.5mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Glimitos M 0.5mg/500mg Tablet PR and seek immediate medical attention.
Glimitos M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's unsuitable for treating type 1 diabetes.
Glimitos M 0.5mg/500mg Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimitos M 0.5mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimitos M 0.5mg/500mg Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimitos M 0.5mg/500mg tablets with alcohol is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimitos M 0.5mg/500mg Ta...
48
MRP 55
12% off